The Jenner Institute team is led by Professors Adrian Hill and Sarah Gilbert. Professor Gilbert said: 'Clinical trials of the universal vaccine here in Oxford have shown great promise. The vaccine has proved safe and shown good clinical responses, including enhanced protection against the flu detectable in older adults even one year after vaccination. It has performed well when given with the standard flu vaccine.'
Universal flu vaccine under development by Oxford spinout Vaccitech
18 May 2016
Oxford spinout company Vaccitech has been launched with £10m seed investment to develop a universal flu vaccine already showing promise in clinical trials.